Neoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal Cancer

NCT07403877 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer (MSI-H)

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab (1mg/kg)
RADIATION: PULSAR
PROCEDURE: Radical surgery
OTHER: Watch & wait

Sponsor

Fudan University